Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.990 | 5.990 | 0.000 |
Shares | 96.590 | 96.590 | 0.000 |
Bonds | 0.540 | 0.540 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 23.453 | 21.195 |
Price to Book | 7.067 | 4.173 |
Price to Sales | 4.123 | 2.490 |
Price to Cash Flow | 20.614 | 17.334 |
Dividend Yield | 0.900 | 1.320 |
5 Years Earnings Growth | 25.436 | 13.721 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 77.930 | 94.960 |
Industrials | 6.450 | 2.657 |
Technology | 6.230 | 2.816 |
Consumer Cyclical | 5.160 | 9.334 |
Communication Services | 3.390 | 3.069 |
Utilities | 0.710 | 1.997 |
Real Estate | 0.050 | 2.589 |
Financial Services | 0.040 | 9.419 |
Consumer Defensive | 0.040 | 3.556 |
Number of long holdings: 45
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.29 | 754.16 | +0.82% | |
SPDR S&P Biotech | US78464A8707 | 8.02 | 97.64 | +1.45% | |
Novo Nordisk B | DK0062498333 | 6.78 | 745.4 | -0.73% | |
Intuitive Surgical | US46120E6023 | 5.32 | 536.55 | -2.07% | |
UnitedHealth | US91324P1021 | 4.95 | 605.53 | +2.48% | |
Amgen | US0311621009 | 4.58 | 294.00 | -0.18% | |
HCA | US40412C1018 | 3.99 | 325.50 | +0.18% | |
Boston Scientific | US1011371077 | 3.97 | 89.25 | -0.84% | |
Universal Health Services | US9139031002 | 3.10 | 199.34 | +0.71% | |
Vertex | US92532F1003 | 2.99 | 461.71 | +2.38% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital India Medium and Small Cap | 15.29B | 27.32 | 20.22 | 12.21 | ||
Capital Asia Pacific Mega Trend Bal | 636.55M | 21.14 | -2.59 | 2.72 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review